Larisa Miller

617 total citations
11 papers, 427 citations indexed

About

Larisa Miller is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Larisa Miller has authored 11 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 4 papers in Neurology. Recurrent topics in Larisa Miller's work include Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Larisa Miller is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Peripheral Neuropathies and Disorders (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Larisa Miller collaborates with scholars based in United States, Japan and Germany. Larisa Miller's co-authors include Željko Debeljak, Mirza Bojić, Hrvoje Rimac, Jacqueline Palace, Mary Crossman, Achim Berthele, Xiao Hu, Darren P. Baker, Sean J. Pittock and Meena Subramanyam and has published in prestigious journals such as Neurology, Annals of Neurology and Current Medicinal Chemistry.

In The Last Decade

Larisa Miller

10 papers receiving 419 citations

Peers

Larisa Miller

PFM

NEURO

IMMUN

ONCOL

RHEUM

Elizabeth Hutto United States

Lorna Garnier France

Samantha A. Chalmers United States

Annalisa Schirinzi Italy

Qiuming Zeng China

Vinodh Kakkassery Germany

Zakir Siddiquee United States

José Carlos Martínez Ávila Spain

Ewa Kuca‐Warnawin Poland

Parviz Toossi Iran

Elizabeth Hutto United States

Larisa Miller

137 ×0.8

PFM

50 ×0.4

NEURO

149 ×1.2

IMMUN

105 ×1.1

ONCOL

91 ×1.1

RHEUM

Citations per year, relative to Larisa Miller Larisa Miller (= 1×) peers Elizabeth Hutto

Countries citing papers authored by Larisa Miller

Since Specialization

Citations

This map shows the geographic impact of Larisa Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Miller more than expected).

Fields of papers citing papers by Larisa Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larisa Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Miller. The network helps show where Larisa Miller may publish in the future.

Co-authorship network of co-authors of Larisa Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Larisa Miller. A scholar is included among the top collaborators of Larisa Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larisa Miller. Larisa Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Pittock, Sean J., Kazuo Fujihara, Jacqueline Palace, et al.. (2021). Long-term efficacy and safety of eculizumab monotherapy in AQP4+ neuromyelitis optica spectrum disorder (1578). Neurology. 96(15_supplement). 1 indexed citations

Kim, Ho Jin, Ichiro Nakashima, Shanthi Viswanathan, et al.. (2021). Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension. Multiple Sclerosis and Related Disorders. 50. 102849–102849. 8 indexed citations

Pittock, Sean J., Kazuo Fujihara, Jacqueline Palace, et al.. (2021). Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension. Multiple Sclerosis Journal. 28(3). 480–486. 45 indexed citations

Wingerchuk, Dean M., Kazuo Fujihara, Jacqueline Palace, et al.. (2021). Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD. Annals of Neurology. 89(6). 1088–1098. 59 indexed citations

Oreja‐Guevara, Celia, Jacqueline Palace, S J Pittock, et al.. (2020). Regional outcomes of eculizumab treatment in patients with aquaporin-4 immunoglobin G-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study. European Journal of Neurology. 27. 90–90. 1 indexed citations

Rimac, Hrvoje, Željko Debeljak, Mirza Bojić, & Larisa Miller. (2017). Displacement of Drugs from Human Serum Albumin: From Molecular Interactions to Clinical Significance. Current Medicinal Chemistry. 24(18). 1930–1947. 35 indexed citations

Miller, Larisa, et al.. (2015). Pathologic patterns of interleukin 10 expression – A review. Biochemia Medica. 25(1). 36–48. 153 indexed citations

Miller, Larisa. (2014). Counting Context: C. E. Kelsey's 1906 Census of Nonreservation Indians in Northern California. American Indian Culture and Research Journal. 38(2). 41–66.

Hu, Xiao, Larisa Miller, Sandra Richman, et al.. (2011). A Novel PEGylated Interferon Beta‐1a for Multiple Sclerosis: Safety, Pharmacology, and Biology. The Journal of Clinical Pharmacology. 52(6). 798–808. 91 indexed citations

10.

Baker, Darren P., R. Blake Pepinsky, Margot Brickelmaier, et al.. (2010). PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis. Journal of Interferon & Cytokine Research. 30(10). 777–785. 32 indexed citations

11.

Davar, Gudarz, Sandra Richman, Meena Subramanyam, et al.. (2009). Pharmacokinetic, pharmacodynamic, and safety profiles of PEGylated interferon beta-1a in healthy volunteers: Results from two Phase 1 clinical studies. Cytokine. 48(1-2). 21–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact